Alkermes discloses preliminary FY2025 total revenue at J.P. Morgan Healthcare Conference

Alkermes plc.

Presentation includes estimated total revenues for year ended Dec. 31, 2025, which are preliminary and unaudited.
No specific revenue figures or other financial details available in the furnished exhibit text.
Investors advised to await final audited financials; conference presentation may contain additional context.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.